ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hepatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 14

$858K Total Retail Price of All Prescriptions

Rank: 2 out of 14

250 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 1,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$195 was the average price of a prescription from this provider, compared to $348 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
URSODIOL 481 195 10 1 1
TACROLIMUS 248 129 10 2 6
MYCOPHENOLATE MOFETIL 220 96 10 3 10
OMEPRAZOLE 178 80 4 2
PANTOPRAZOLE SODIUM 178 70 4 11
FLUDROCORTISONE ACETATE 159 44 10 6 12
METOPROLOL TARTRATE 157 61 7 13
PREDNISONE 153 44 8 8
FUROSEMIDE 152 29 9 3
PROGRAF 124 73 10 19
LAMIVUDINE 95 43 11 24
VIREAD 88 49 12 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 37 13 27
AMLODIPINE BESYLATE 78 18 14 7
RIBAVIRIN 75 57 15 28
HEPSERA 66 46 10 16 32
HYDROCODONE-ACETAMINOPHEN 62 28 S3 17 33
XIFAXAN 60 11 18 5
BARACLUDE 58 44 19 9
SPIRONOLACTONE 54 17 20 4
NEXIUM 52 23 21 39
FAMOTIDINE 52 31 21 39
RAPAMUNE 52 0 21 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.